Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MADRID, Spain, June 26, 2020 (GLOBE NEWSWIRE) -- Highlight Therapeutics ("Highlight"), a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces the dosing...
-
Dr Ralph Weichselbaum, Dr. Antoni Ribas & Michael Docherty appointed to SAB Company renamed to Highlight Therapeutics MADRID, Spain, April 17, 2020 (GLOBE NEWSWIRE) -- Highlight Therapeutics...
-
MADRID, Spain, April 17, 2020 (GLOBE NEWSWIRE) -- Highlight Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces that it has changed its...
-
MADRID, Spain, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Bioncotech Therapeutics ("Bioncotech"), a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces the...
-
MADRID, Spain, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Bioncotech Therapeutics ("Bioncotech"), a clinical-stage biopharmaceutical company developing RNA-based therapies against cancer, announces it has...